Surgical and oncologic outcomes in surgically treated women 80 years and older with endometrioid endometrial cancer as a function of their comorbidities

Objective: To describe the surgical and oncologic outcomes in surgically treated oldest old women (≥80 years) with endometrioid endometrial cancer as a function of their comorbidities. Methods: In this retrospective cohort study, patients aged 80-99 years who underwent surgical management of stage I...

Full description

Saved in:
Bibliographic Details
Main Authors: Abdelrahman AlAshqar (Author), Maddie Ghazarian (Author), Emily M. Webster (Author), Animesh Upadhyay (Author), Masoud Azodi (Author), Peter E. Schwartz (Author), Elena Ratner (Author), Gary Altwerger (Author)
Format: Book
Published: Elsevier, 2023-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_1dd4e0249f084913b7d65e5f2adc83a0
042 |a dc 
100 1 0 |a Abdelrahman AlAshqar  |e author 
700 1 0 |a Maddie Ghazarian  |e author 
700 1 0 |a Emily M. Webster  |e author 
700 1 0 |a Animesh Upadhyay  |e author 
700 1 0 |a Masoud Azodi  |e author 
700 1 0 |a Peter E. Schwartz  |e author 
700 1 0 |a Elena Ratner  |e author 
700 1 0 |a Gary Altwerger  |e author 
245 0 0 |a Surgical and oncologic outcomes in surgically treated women 80 years and older with endometrioid endometrial cancer as a function of their comorbidities 
260 |b Elsevier,   |c 2023-10-01T00:00:00Z. 
500 |a 2352-5789 
500 |a 10.1016/j.gore.2023.101240 
520 |a Objective: To describe the surgical and oncologic outcomes in surgically treated oldest old women (≥80 years) with endometrioid endometrial cancer as a function of their comorbidities. Methods: In this retrospective cohort study, patients aged 80-99 years who underwent surgical management of stage I endometrioid endometrial cancer between 2006 and 2018 were included. Low- and high-intermediate risk disease was defined using the Gynecologic Oncology Group-99 criteria. The validated, Combined Age-Charlson Comorbidity Index (CA-CCI) was used to quantify comorbidity burden. Logistic regression was used to identify the independent predictors of various surgical and oncologic outcomes. Kaplan-Meier survival analysis was performed to compare survival distributions based on mortality cause and comorbidity status. Results: We identified 64 women who met the eligibility criteria. Median age was 84 years (IQR 80, 94 years). Among oldest old women undergoing a hysterectomy with or without lymph node dissection, women with a CA-CCI score of ≥7 had an 8 times higher risk of postoperative infections compared with oldest old women with a <7 score (95% CI 1.53-48.91, P = 0.015). Women with a CA-CCI score of ≥8 were 45% less likely to survive at 3 years (aRR 0.55, 95% CI 0.004-0.87; P = 0.039) than those with a lower CA-CCI score (three-year overall survival 73% vs 96%). Conclusion: Surgical and oncologic outcomes in oldest old women with early stage endometrioid endometrial cancer are largely determined by comorbidity status. Less comorbid women (CA-CCI score < 8) had a significantly higher five-year survival at 87% than their more comorbid counterparts. Use of age-comorbidity risk scoring such as CA-CCI, preoperative optimization, and careful selection for and counseling of patients about surgical treatment are paramount in providing optimal recovery and survival advantages in the oldest old. 
546 |a EN 
690 |a Cancer survival 
690 |a Comorbidity Index 
690 |a Older women 
690 |a Mortality 
690 |a Postoperative outcomes 
690 |a Uterine cancer 
690 |a Gynecology and obstetrics 
690 |a RG1-991 
690 |a Neoplasms. Tumors. Oncology. Including cancer and carcinogens 
690 |a RC254-282 
655 7 |a article  |2 local 
786 0 |n Gynecologic Oncology Reports, Vol 49, Iss , Pp 101240- (2023) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2352578923001091 
787 0 |n https://doaj.org/toc/2352-5789 
856 4 1 |u https://doaj.org/article/1dd4e0249f084913b7d65e5f2adc83a0  |z Connect to this object online.